These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 10842655)

  • 1. Mechanisms of hypertension and kidney disease in obesity.
    Hall JE; Brands MW; Henegar JR
    Ann N Y Acad Sci; 1999 Nov; 892():91-107. PubMed ID: 10842655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal kidney function as a cause and a consequence of obesity hypertension.
    Hall JE; Brands MW; Henegar JR; Shek EW
    Clin Exp Pharmacol Physiol; 1998 Jan; 25(1):58-64. PubMed ID: 9493561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of abnormal renal sodium handling in obesity hypertension.
    Hall JE
    Am J Hypertens; 1997 May; 10(5 Pt 2):49S-55S. PubMed ID: 9160781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is obesity a major cause of chronic kidney disease?
    Hall JE; Henegar JR; Dwyer TM; Liu J; Da Silva AA; Kuo JJ; Tallam L
    Adv Ren Replace Ther; 2004 Jan; 11(1):41-54. PubMed ID: 14730537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of obesity hypertension.
    Hall JE
    Curr Hypertens Rep; 2000 Apr; 2(2):139-47. PubMed ID: 10981140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity.
    Hall JE
    Hypertension; 1994 Mar; 23(3):381-94. PubMed ID: 8125566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.
    Hall JE; do Carmo JM; da Silva AA; Wang Z; Hall ME
    Circ Res; 2015 Mar; 116(6):991-1006. PubMed ID: 25767285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kidney, hypertension, and obesity.
    Hall JE
    Hypertension; 2003 Mar; 41(3 Pt 2):625-33. PubMed ID: 12623970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal consequences of obesity.
    Naumnik B; Myśliwiec M
    Med Sci Monit; 2010 Aug; 16(8):RA163-70. PubMed ID: 20671624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of sympathetic nervous system and neuropeptides in obesity hypertension.
    Hall JE; Brands MW; Hildebrandt DA; Kuo J; Fitzgerald S
    Braz J Med Biol Res; 2000 Jun; 33(6):605-18. PubMed ID: 10829088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the obesity epidemic on hypertension and renal disease.
    Hall JE; Jones DW; Kuo JJ; da Silva A; Tallam LS; Liu J
    Curr Hypertens Rep; 2003 Oct; 5(5):386-92. PubMed ID: 12948431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology and treatment of obesity hypertension.
    Wofford MR; Hall JE
    Curr Pharm Des; 2004; 10(29):3621-37. PubMed ID: 15579059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity, kidney dysfunction, and inflammation: interactions in hypertension.
    Hall JE; Mouton AJ; da Silva AA; Omoto ACM; Wang Z; Li X; do Carmo JM
    Cardiovasc Res; 2021 Jul; 117(8):1859-1876. PubMed ID: 33258945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function in one-kidney, one-clip hypertension and low renin essential hypertension.
    Hall JE
    Am J Hypertens; 1991 Oct; 4(10 Pt 2):523S-533S. PubMed ID: 1741989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
    Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS
    Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of obesity-induced hypertension.
    Kotsis V; Stabouli S; Papakatsika S; Rizos Z; Parati G
    Hypertens Res; 2010 May; 33(5):386-93. PubMed ID: 20442753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension: physiology and pathophysiology.
    Hall JE; Granger JP; do Carmo JM; da Silva AA; Dubinion J; George E; Hamza S; Speed J; Hall ME
    Compr Physiol; 2012 Oct; 2(4):2393-442. PubMed ID: 23720252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity-associated hypertension and kidney disease.
    Hall JE; Kuo JJ; da Silva AA; de Paula RB; Liu J; Tallam L
    Curr Opin Nephrol Hypertens; 2003 Mar; 12(2):195-200. PubMed ID: 12589181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal mechanisms of angiotensin II-induced hypertension.
    Granger JP; Schnackenberg CG
    Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity, hypertension, and chronic kidney disease.
    Hall ME; do Carmo JM; da Silva AA; Juncos LA; Wang Z; Hall JE
    Int J Nephrol Renovasc Dis; 2014; 7():75-88. PubMed ID: 24600241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.